Currently, one key feature of TSC1/TSC2 biology is well understood: the ability of the TSC1/2 tumour suppressor complex to inhibit growth signalling through mechanistic target of rapamycin complex 1 (mTORC1). The gene discussed is TSC2; the disease is neoplasm.